Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Scholar Rock Holding Corporation (SRRK)
Last scholar rock holding corporation earnings: 11/12 07:30 am
Check Earnings Report
Company Research
Source: Business Wire
Apitegromab Biologics License Application (BLA) resubmission and U.S. launch, following FDA approval, are anticipated in 2026 for the treatment of children and adults with spinal muscular atrophy (SMA)FDA completed constructive meeting with Catalent Indiana, LLC (part of Novo Nordisk), with discussion of remediation progress and no additional corrective actions requested by FDAScholar Rock plans to resubmit BLA upon successful FDA reinspection of Catalent IndianaApitegromab Marketing Authorisation Application (MAA) review ongoing, with EMA decision anticipated in mid-2026; European launch expected in H2 2026, starting with GermanySecured new debt facility, providing up to $550 million in non-dilutive capital to support commercialization of apitegromab and strategic advancement of key pipeline programsCash, cash equivalents, and marketable securities of $367.6 million as of December 31, 2025Management to host conference call today at 8:00 a.m. ET CAMBRIDGE, Mass.--(BUSINESS WIRE)--S
Show less
Read more
Impact Snapshot
Event Time:
SRRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRRK alerts
High impacting Scholar Rock Holding Corporation news events
Weekly update
A roundup of the hottest topics
SRRK
News
- Scholar Rock (SRRK) had its price target raised by Citigroup Inc. from $55.00 to $58.00. They now have a "buy" rating on the stock.MarketBeat
- Scholar Rock (SRRK) had its price target raised by BMO Capital Markets from $50.00 to $70.00. They now have an "outperform" rating on the stock.MarketBeat
- Scholar Rock (SRRK) had its price target raised by Piper Sandler from $51.00 to $58.00. They now have an "overweight" rating on the stock.MarketBeat
- Scholar Rock (SRRK) had its "overweight" rating reaffirmed by Barclays PLC.MarketBeat
- Scholar Rock (SRRK) was given a new $55.00 price target by Truist Financial Corporation.MarketBeat
SRRK
Earnings
- 3/3/26 - Miss
SRRK
Sec Filings
- 3/3/26 - Form 8-K/A
- 3/3/26 - Form S-8
- 3/3/26 - Form 10-K
- SRRK's page on the SEC website